$3.58B Market Cap.
DNA Market Cap. (MRY)
DNA Shares Outstanding (MRY)
DNA Assets (MRY)
Total Assets
$1.67B
Total Liabilities
$568.19M
Total Investments
$78.56M
DNA Income (MRY)
Revenue
$251.46M
Net Income
-$892.87M
Operating Expense
$1.06B
DNA Cash Flow (MRY)
CF Operations
-$295.50M
CF Investing
-$80.69M
CF Financing
-$3.22M
DNA Dividends (MRY)
Period | Dividends | Yield % | Growth % | Payout Ratio | Coverage Ratio |
---|---|---|---|---|---|
2023 | $0 | 0% | 0% | 0% | - |
2022 | $0 | 0% | 0% | 0% | - |
2021 | $0 | 0% | 0% | 0% | - |
2020 | $0 | - | 0% | 0% | - |
2019 | $0 | - | - | 0% | - |
DNA Balance Sheet (MRY)
Metric | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|
Total Assets | $1,665,342,000 (-34.42%) | $2,539,321,000 (22.61%) | $2,070,990,000 (206.74%) | $675,153,000 (-3.18%) |
Assets Current | $1,001,749,000 (-30.92%) | $1,450,079,000 (-15.84%) | $1,723,045,000 (303.96%) | $426,542,000 (-16.68%) |
Assets Non-Current | $663,593,000 (-39.08%) | $1,089,242,000 (213.05%) | $347,945,000 (39.96%) | $248,611,000 (34.10%) |
Goodwill & Intangible Assets | $131,979,000 (-22.93%) | $171,251,000 (298.68%) | $42,954,000 (733.90%) | $5,151,000 (-9.63%) |
Shareholders Equity | $1,097,152,000 (-36.81%) | $1,736,277,000 (15.34%) | $1,505,365,000 (226.28%) | $461,376,000 (-6.43%) |
Property Plant & Equipment Net | $394,994,000 (-44.80%) | $715,535,000 (390.87%) | $145,770,000 (20.04%) | $121,435,000 (92.35%) |
Cash & Equivalents | $944,073,000 (-28.25%) | $1,315,792,000 (-15.11%) | $1,550,004,000 (307.04%) | $380,801,000 (-23.12%) |
Accumulated Other Comprehensive Income | $1,484,000 (156.38%) | -$2,632,000 (-53.47%) | -$1,715,000 (0%) | $0 (0%) |
Deferred Revenue | $202,548,000 (-9.00%) | $222,584,000 (17.63%) | $189,231,000 (47.29%) | $128,475,000 (-13.13%) |
Total Investments | $78,565,000 (-30.92%) | $113,731,000 (-1.30%) | $115,231,000 (-1.02%) | $116,422,000 (4.91%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $78,565,000 (-30.92%) | $113,731,000 (-1.30%) | $115,231,000 (-1.02%) | $116,422,000 (4.91%) |
Inventory | $0 (0%) | $4,364,000 (29.80%) | $3,362,000 (22.88%) | $2,736,000 (0%) |
Trade & Non-Trade Receivables | $17,899,000 (-78.30%) | $82,465,000 (-39.43%) | $136,142,000 (521.48%) | $21,906,000 (185.31%) |
Trade & Non-Trade Payables | $9,323,000 (-10.79%) | $10,451,000 (27.62%) | $8,189,000 (-41.06%) | $13,893,000 (469.62%) |
Accumulated Retained Earnings (Deficit) | -$5,290,528,000 (-20.30%) | -$4,397,659,000 (-91.38%) | -$2,297,925,000 (-391.14%) | -$467,878,000 (-37.10%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $221,835,000 (-46.32%) | $413,256,000 (1754.58%) | $22,283,000 (34.90%) | $16,518,000 (-1.49%) |
Debt Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Debt Non-Current | $221,835,000 (-46.32%) | $413,256,000 (1754.58%) | $22,283,000 (34.90%) | $16,518,000 (-1.49%) |
Total Liabilities | $568,190,000 (-29.25%) | $803,044,000 (59.46%) | $503,611,000 (145.54%) | $205,101,000 (4.93%) |
Liabilities Current | $163,860,000 (-5.26%) | $172,962,000 (28.35%) | $134,761,000 (84.05%) | $73,221,000 (82.71%) |
Liabilities Non-Current | $404,330,000 (-35.83%) | $630,082,000 (70.82%) | $368,850,000 (179.69%) | $131,880,000 (-15.13%) |
DNA Income Statement (MRY)
Metric | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|
Revenues | $251,455,000 (-47.36%) | $477,706,000 (52.21%) | $313,837,000 (309.40%) | $76,657,000 (41.48%) |
Cost of Revenue | $54,005,000 (-73.55%) | $204,216,000 (57.46%) | $129,690,000 (730.76%) | $15,611,000 (0%) |
Selling General & Administrative Expense | $385,025,000 (-73.07%) | $1,429,799,000 (65.69%) | $862,952,000 (2152.79%) | $38,306,000 (29.93%) |
Research & Development Expense | $580,621,000 (-44.84%) | $1,052,643,000 (-8.44%) | $1,149,662,000 (619.59%) | $159,767,000 (65.91%) |
Operating Expenses | $1,061,856,000 (-57.23%) | $2,482,442,000 (23.34%) | $2,012,614,000 (916.10%) | $198,073,000 (57.47%) |
Interest Expense | $93,000 (-12.26%) | $106,000 (-95.53%) | $2,373,000 (-0.50%) | $2,385,000 (-1.49%) |
Income Tax Expense | -$71,000 (99.53%) | -$15,027,000 (-915.34%) | -$1,480,000 (-178.35%) | $1,889,000 (8486.36%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$892,869,000 (57.61%) | -$2,106,372,000 (-14.69%) | -$1,836,642,000 (-1349.34%) | -$126,723,000 (-5.73%) |
Net Income to Non-Controlling Interests | $0 (0%) | -$1,443,000 (78.12%) | -$6,595,000 (-5685.09%) | -$114,000 (78.49%) |
Net Income | -$892,869,000 (57.58%) | -$2,104,929,000 (-15.02%) | -$1,830,047,000 (-1345.43%) | -$126,609,000 (-6.10%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$892,869,000 (57.58%) | -$2,104,929,000 (-15.02%) | -$1,830,047,000 (-1345.43%) | -$126,609,000 (-6.10%) |
Weighted Average Shares | $1,944,420,000 (15.80%) | $1,679,061,465 (23.47%) | $1,359,848,803 (6.67%) | $1,274,766,915 (10.95%) |
Weighted Average Shares Diluted | $1,944,420,000 (15.75%) | $1,679,838,849 (23.48%) | $1,360,373,343 (6.72%) | $1,274,766,915 (10.95%) |
Earning Before Interest & Taxes (EBIT) | -$892,847,000 (57.88%) | -$2,119,850,000 (-15.89%) | -$1,829,154,000 (-1395.20%) | -$122,335,000 (-4.66%) |
Gross Profit | $197,450,000 (-27.80%) | $273,490,000 (48.52%) | $184,147,000 (201.65%) | $61,046,000 (12.66%) |
Operating Income | -$864,406,000 (60.87%) | -$2,208,952,000 (-20.81%) | -$1,828,467,000 (-1234.38%) | -$137,027,000 (-91.38%) |
DNA Cash Flow Statement (MRY)
Metric | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|
Net Cash Flow from Investing | -$80,693,000 (-19.73%) | -$67,394,000 (8.00%) | -$73,257,000 (-9.14%) | -$67,121,000 (10.03%) |
Net Cash Flow from Financing | -$3,216,000 (-103.37%) | $95,337,000 (-93.79%) | $1,534,145,000 (1598.60%) | $90,318,000 (-77.99%) |
Net Cash Flow from Operations | -$295,500,000 (-17.17%) | -$252,198,000 (0.64%) | -$253,818,000 (-86.86%) | -$135,830,000 (-204.12%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$379,997,000 (-70.14%) | -$223,347,000 (-118.50%) | $1,207,051,000 (1171.67%) | -$112,633,000 (-138.69%) |
Net Cash Flow - Business Acquisitions and Disposals | -$43,330,000 (-106.40%) | -$20,993,000 (-74.36%) | -$12,040,000 (-19.21%) | -$10,100,000 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $6,309,000 (234.35%) | -$4,696,000 (-687.00%) | $800,000 (101.53%) |
Capital Expenditure | -$36,373,000 (30.41%) | -$52,271,000 (7.52%) | -$56,521,000 (2.25%) | -$57,821,000 (-160.23%) |
Issuance (Repayment) of Debt Securities | -$1,295,000 (-4.69%) | -$1,237,000 (-10.15%) | -$1,123,000 (-50.13%) | -$748,000 (-100.38%) |
Issuance (Purchase) of Equity Shares | -$487,000 (-100.50%) | $98,076,000 (-93.39%) | $1,484,798,000 (5710661.54%) | $26,000 (106.48%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | -$588,000 (-164.76%) | $908,000 (4878.95%) | -$19,000 (0%) | $0 (0%) |
Share Based Compensation | $229,884,000 (-88.09%) | $1,930,641,000 (20.21%) | $1,606,020,000 (337299.16%) | $476,000 (-38.26%) |
Depreciation Amortization & Accretion | $99,867,000 (57.26%) | $63,505,000 (118.41%) | $29,076,000 (109.72%) | $13,864,000 (28.91%) |
DNA Financial Metrics (MRY)
Metric | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|
Gross Margin | 78.50% (37.00%) | 57.30% (-2.39%) | 58.70% (-26.26%) | 79.60% (-20.40%) |
Profit Margin | -355.10% (19.41%) | -440.60% (24.44%) | -583.10% (-252.97%) | -165.20% (24.98%) |
EBITDA Margin | -315.40% (26.74%) | -430.50% (24.95%) | -573.60% (-305.37%) | -141.50% (27.77%) |
Return on Average Equity (ROAE) | -65.40% (51.16%) | -133.90% (30.59%) | -192.90% (-627.92%) | -26.50% |
Return on Average Assets (ROAA) | -42.50% (57.29%) | -99.50% (25.91%) | -134.30% (-629.89%) | -18.40% |
Return on Sales (ROS) | -355.10% (19.99%) | -443.80% (23.85%) | -582.80% (-265.16%) | -159.60% (26.01%) |
Return on Invested Capital (ROIC) | -84.50% (74.36%) | -329.50% (46.27%) | -613.20% (-916.92%) | -60.30% |
Dividend Yield | 0% (0%) | 0% (0%) | 0% | - |
Price to Earnings Ratio (P/E) | -3.67 (-171.75%) | -1.35 (78.04%) | -6.16 | - |
Price to Sales Ratio (P/S) | 13.07 (120.00%) | 5.94 (-83.50%) | 36.01 | - |
Price to Book Ratio (P/B) | 3.26 (72.83%) | 1.89 (-77.00%) | 8.21 | - |
Debt to Equity Ratio (D/E) | 0.52 (11.88%) | 0.46 (38.21%) | 0.34 (-24.72%) | 0.45 (12.37%) |
Earnings Per Share (EPS) | -0.46 (63.20%) | -1.25 (7.41%) | -1.35 (-1250.00%) | -0.1 (0.00%) |
Sales Per Share (SPS) | 0.13 (-54.74%) | 0.28 (23.38%) | 0.23 (285.00%) | 0.06 (27.66%) |
Free Cash Flow Per Share (FCFPS) | -0.17 (5.52%) | -0.18 (20.61%) | -0.23 (-50.00%) | -0.15 (-162.07%) |
Book Value Per Share (BVPS) | 0.56 (-45.45%) | 1.03 (-6.59%) | 1.11 (205.80%) | 0.36 (-15.62%) |
Tangible Assets Book Value Per Share (TABVPS) | 0.79 (-44.04%) | 1.41 (-5.43%) | 1.49 (183.46%) | 0.53 (-12.62%) |
Enterprise Value Over EBIT (EV/EBIT) | -3 (-200.00%) | -1 (83.33%) | -6 | - |
Enterprise Value Over EBITDA (EV/EBITDA) | -3.7 (-273.84%) | -0.99 (83.24%) | -5.91 | - |
Asset Turnover | 0.12 (-46.90%) | 0.23 (-1.74%) | 0.23 (105.36%) | 0.11 |
Current Ratio | 6.11 (-27.09%) | 8.38 (-34.43%) | 12.79 (119.50%) | 5.83 (-54.40%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$331,873,000 (-9.00%) | -$304,469,000 (1.89%) | -$310,339,000 (-60.26%) | -$193,651,000 (-189.54%) |
Enterprise Value (EV) | $2,934,575,780 (44.15%) | $2,035,804,972 (-80.85%) | $10,631,973,817 | - |
Earnings Before Tax (EBT) | -$892,940,000 (57.88%) | -$2,119,956,000 (-15.75%) | -$1,831,527,000 (-1368.51%) | -$124,720,000 (-4.54%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$792,980,000 (61.44%) | -$2,056,345,000 (-14.24%) | -$1,800,078,000 (-1559.50%) | -$108,471,000 (-2.21%) |
Invested Capital | $647,265,000 (-49.92%) | $1,292,572,000 (253.59%) | $365,554,000 (57.23%) | $232,498,000 (34.37%) |
Working Capital | $837,889,000 (-34.39%) | $1,277,117,000 (-19.59%) | $1,588,284,000 (349.53%) | $353,321,000 (-25.12%) |
Tangible Asset Value | $1,533,363,000 (-35.25%) | $2,368,070,000 (16.77%) | $2,028,036,000 (202.69%) | $670,002,000 (-3.13%) |
Market Capitalization | $3,580,157,780 (9.20%) | $3,278,565,972 (-73.46%) | $12,354,761,817 | - |
Average Equity | $1,365,251,500 (-13.14%) | $1,571,809,750 (65.72%) | $948,465,000 (98.75%) | $477,219,500 |
Average Assets | $2,100,235,500 (-0.72%) | $2,115,490,250 (55.20%) | $1,363,031,250 (98.62%) | $686,235,500 |
Invested Capital Average | $1,056,850,250 (64.28%) | $643,332,750 (115.68%) | $298,287,750 (47.11%) | $202,761,000 |
Shares | 2,118,436,556 (9.20%) | 1,939,979,865 (30.49%) | 1,486,734,274 (589.50%) | 215,625,000 |